As patients take a more proactive role in their own health care, direct-to-consumer (DTC) laboratory testing is becoming increasingly popular. DTC genetic tests allow consumers to access information about their genetics without necessarily involving healthcare professionals in the process. 

A number of established and emerging companies are competing in this growing market. Kalorama Information, a healthcare market research firm, recently profiled a variety of prominent market participants in its report The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing. This blog post highlights 9 of these companies that are among the leaders in the industry.

The long-term care market in the United States reached $305 billion last year, according to a new report by Kalorama Information, a healthcare market research firm own by MarketResearch.com. Long-term care encompasses a continuum of services including home care, assisted living, hospice, and skilled nursing care. It is estimated that two out of five Americans will need long-term care at some point in their lives. The vast majority of people using long-term care services are senior citizens.

The U.S. demand for drug delivery products is projected to reach $251 billion in 2019, according to the Freedonia Group, a leading international business research company. Oral dosage formulations will remain the largest-selling group of drug delivery products over the long term, but patent expirations and competition from generic brands will soften the growth potential of this product segment overall. Drawing on key findings from Freedonia's recent study Drug Delivery Products, here’s a look at the market outlook for oral medications, including controlled-release formulations and niche applications.

MarketResearch.com is a leading provider of business intelligence, offering users access to timely information about hundreds of industries. In partnership with Kalorama Information, MarketResearch.com provides high-quality research and analysis to key decision makers in life science firms.

Life science market research includes broad topics such as biotechnology, healthcare, pharmaceuticals, medical devices, and diagnostics. New and established companies need to be aware of influential changes that may alter how healthcare is delivered and the patient's experience and outcomes. Our white papers and market research reports explain the market sectors and healthcare trends that matter most. Below is a list of our latest white papers with insights into this rapidly changing industry.

February is American Heart Month, a time dedicated to spreading awareness of cardiovascular disease, also known as heart disease. Cardiovascular disease (CVD) includes heart attack, arrhythmia, heart valve problems, and the after effects of stroke. CVD is the leading cause of death in the world and in the U.S.

Read on to learn key facts about heart disease and what these statistics could mean for the healthcare industry.

The mobile health market could reach an astounding $86.6 billion by 2020, a yearly increase of 20.8 percent over a five-year period, according to Kalorama Information. In the race to re-imagine patient care, a number of innovative companies are creating new, breakthrough solutions that allow patients to access medical care from the comfort of their homes.

Whether you’d like to to text a therapist, or video conference with a doctor, a variety of services and mobile apps are being released to accommodate different needs and preferences. This dynamic field is quickly becoming crowded with competitors, and we can expect to see big shifts in the coming years as companies jostle for position and test new business models.

Healthcare is one of the most dynamic application of cloud computing. Although healthcare organizations are highly concerned about the privacy and security of patient data, the pressure of controlling the increasing healthcare cost has driven the adoption of cost effective solutions such as cloud computing. There has been a surge of interest of the healthcare companies in adoption of cloud computing. A report estimates cloud healthcare market will grow at nearly 25% through 2020.

The Chinese economy has grown substantially from a GDP of $1,931 billion in 2004 to reach $10,355 billion across 2014, a 10-year CAGR of 10.3%. Many analysts forecast that Chinese GDP will surpass US GDP, currently the globe's largest, by 2020; some forecast even sooner. This rise in GDP has been mirrored across many sectors in China, with increased levels of spending in public infrastructure, manufacturing, healthcare and many, many other domestic industries.

China is one of the world’s fastest growing economies, housing a fifth of the global population and one of the largest healthcare markets around the world. Along with sustained economic and population growth, as well as an aging population, the Chinese healthcare market has maintained an annual average growth rate above 16% since the1990’s. In 2014, the total value of medical devices in the Chinese healthcare market reached RMB 259.5 billion (approx US$41.8 billion). Imported medical devices made by overseas and multinational companies account for about a half. Many high-tech and high-valued medical devices, such as magnetic resonance imaging (MRI) equipment and computed tomography (CT) equipment, are almost monopolized by GE, Siemens, Philips and other overseas and multinational companies.

Telemedicine is increasingly gaining popularity due to its high potential for cost savings and increased efficiency in healthcare. Expert medical care through telemedicine can significantly improve the healthcare facilities at rural and remote locations. Advanced wireless and networking technologies coupled with recent advances in biotechnology, biosensors and software engineering has enabled the promising growth in telemedicine healthcare systems.